Suggestions
Qingqing Wang
Senior Principal Scientist at Regeneron Pharmaceuticals, Inc.
Qingqing Wang is a Senior Principal Scientist at Regeneron Pharmaceuticals, where she specializes in RNA biology, systems biology, and computational biology. Her academic background includes a Ph.D. from Harvard University, where she conducted research under the guidance of Pamela Silver, focusing on alternative splicing regulation in programmed cell death and neurological disorders .12
Her work has contributed significantly to the understanding of alternative splicing mechanisms, with several publications in prominent scientific journals. Notable research includes studies on the link between cell-cycle control and apoptosis, as well as the impact of intron retention in neurodegenerative diseases like ALS .24
Before her current position at Regeneron, Wang held roles as a scientist and postdoctoral researcher at various institutions, including the University of California .3 Her expertise is recognized in the field, evidenced by her numerous citations and contributions to significant research projects .2